Adani Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 4.54 M
as on 23-10-2024
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 18.55 Cr
as on 23-10-2024
- Revenue 20.00%
(FY 2023)
- Profit -69.19%
(FY 2023)
- Ebitda -26.11%
(FY 2023)
- Net Worth 6.84%
(FY 2023)
- Total Assets -8.32%
(FY 2023)
About Adani Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.54 M.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹18.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rushabh Adani and Nirali Adani serve as directors at the Company.
- CIN/LLPIN
U24231GJ1999PTC035693
- Company No.
035693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 1999
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Adani Pharmachem Private Limited offer?
Adani Pharmachem Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Iodine Compounds, Animal Medicines & Health Care, Veterinary Medicines.
Who are the key members and board of directors at Adani Pharmachem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushabh Adani  | Managing Director | 01-Apr-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirali Adani | Director | 07-Jan-2011 | Current |
Financial Performance of Adani Pharmachem.
Adani Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20% increase. The company also saw a substantial fall in profitability, with a 69.19% decrease in profit. The company's net worth moved up by a moderate rise of 6.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adani Pharmachem?
In 2022, Adani Pharmachem had a promoter holding of 95.69% and a public holding of 4.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 15 Dec 2017 | ₹15.00 Cr | Open |
Others Creation Date: 03 Sep 2004 | ₹17.27 Cr | Satisfied |
Bank Of Baroda Creation Date: 15 Apr 2002 | ₹1.28 Cr | Satisfied |
How Many Employees Work at Adani Pharmachem?
Adani Pharmachem has a workforce of 50 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adani Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adani Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
